Yesterday evening, B.R.A.I.N. Biotechnology Research and Information Network AG (“BRAIN AG”, ISIN DE0005203947 / WKN 520394) was informed that after the end of the one-year lock-up period, MIG Fonds, as existing shareholders of the company, sold its entire stake of 2,528,389 shares to more than 20 institutional investors. The placement took place outside the stock market as part of an accelerated book-building process. The transaction, which was oversubscribed several times, was accompanied by ODDO SEYDLER BANK AG and Baader Bank AG. The free float of BRAIN shares increased from 22% to 37%.
Dr Jürgen Eck, CEO of BRAIN AG, is pleased about the strong demand from investor interest for the BRAIN share: “The MiG funds are early-stage investors, which provide venture capital for founders and young companies. They have financially supported the development of BRAIN AG for many years and have thus also contributed significantly to our success. I would therefore like to expressly thank you for the excellent and trustworthy cooperation in recent years. The high demand on the part of the investors is a further confirmation of our operating business.”
“As a result of the placement, the free float of BRAIN share has significantly increased, which will also improve the tradability of the share for all investors. I am satisfied that based on the high demand from investors, a successful transaction for the MiG funds could be carried out as Joint Global Coordinator by the accompanying banks ODDO SEYDLER BANK AG together with BAADER BANK AG as joint bookrunners”, says Frank Goebel, Member of the Management Board of BRAIN AG.